Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-503 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 |
filingDate |
2014-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2017-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-105143228-B |
titleOfInvention |
[1,2,4]triazolo[4,3‑a]pyridine derivatives, their preparation method or their application in medicine |
abstract |
Provide a [1,2,4]triazolo[4,3-a]pyridine derivative as shown in the general formula (I), its preparation method and a pharmaceutical composition containing the derivative as a therapeutic agent, Especially as c-Met inhibitor and immunosuppressant purposes, wherein each substituent of the general formula (I) is the same as defined in the description. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109705139-A |
priorityDate |
2013-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |